MU presentation I presented tot he champions.
Survey after presentation is at: http://bit.ly/NYUMUSURVEY
For more details I can be reached at:
leanthonyrn@gmail.com
or LinkedIN
Anurati Mathur & Propeller Health @ Madison's Big Data MeetupAnurati Mathur
Using healthcare data - context & considerations for collecting, cleansing, analyzing, and displaying geospatial and temporal data, with a focus on Propeller Health's program in Louisville, KY.
Health care consumers benefit from understanding some of the issues involved in providing them with the best care, and some things they can do themselves to prepare for and learn about these issues. Doctors, nurses, and other health professionals dedicate their lives to caring for their patients. But providing health care can be complicated.
The coming era of digital therapeutics nrc live - sept 2018Chris Hogg
Thoughts on the past, present and future of digital therapeutics and digital medicines. Presentation for NRC Live Zorgtech Conference in Amsterdam, September 2018.
With @Atreja at the NODE Health Conference - Digital Medicine http://digitalmedicineconference.com/ on the events and studies which moved the field forward
PCHAlliance conducted a systematic review of published literature to gather the available data on health outcome measures, reviewing over 1,450 citations. Fifty-three randomized controlled studies and trials were selected for analysis, on topics related to mobile technologies, remote patient monitoring, web-based counseling and other personal connected health technologies. This publication aims to set an initial baseline for the current body of evidence in personal connected health in key areas, namely behavior change and self-care, remote patient monitoring, remote counseling and mental health, as well as more broadly through key condition-specific studies.
Download the paper here: http://www.pchalliance.org/personal-connected-health-state-evidence-and-call-action
Successfully Managing Chronic Health Conditions with Human-Centered Digital T...Cognizant
By adopting evidence-based digital therapeutics, healthcare organizations can alleviate the mounting costs of caring for patients with chronic conditions — and enter the fourth wave of digital healthcare.
Integrated Health Information to Examine, Empower and EngageH-Connect Compusoft
Electronic Ecosystem to build a universal Electronic Health Record and Health information exchange.
Deliver care through information technology,
Enhance health research, analysis & compliance
Improve efficiency, quality and reduce cost of healthcare. Online health records and Clinical Decision Support System (CDSS) at http://www.hconnect.co.in/
Digital is transforming healthcare. In this omnichannel age, patients expect better experience while expectations are often not met. This gap calls for an evolution in patient journey and experience research.
What are Digital Therapeutics? What are Digital Therapeutics not? What qualifies software as therapy? How do we research and develop Digital Therapeutics ? Why can DTx be disruptive? Threats and Opportunities for Pharma
Optimizing your EHR Value through Patient EngagementBrian Ahier
Focusing on the transformed healthcare system enabled by ARRA, hear ideas on how patients can help realize the value of your EHR and help you achieve meaningful use.
Judy Murphy, RN, FACMI, FHIMSS, FAAN
Deputy National Coordinator for Programs and Policy, Office of the National Coordinator for HIT
For more information contact: Slideshare@marcusevans.com
Presentation delivered by Joseph H. Schneider, MD, MBA, FAAP, Vice President and Chief Medical Information Officer and Medical Director, Clinical Informatics, North Texas, Baylor Scott and White Health at the marcus evans National Healthcare CMO/CMIO Summit 2015 at the Ritz-Carlton Buckhead Atlanta.
Anurati Mathur & Propeller Health @ Madison's Big Data MeetupAnurati Mathur
Using healthcare data - context & considerations for collecting, cleansing, analyzing, and displaying geospatial and temporal data, with a focus on Propeller Health's program in Louisville, KY.
Health care consumers benefit from understanding some of the issues involved in providing them with the best care, and some things they can do themselves to prepare for and learn about these issues. Doctors, nurses, and other health professionals dedicate their lives to caring for their patients. But providing health care can be complicated.
The coming era of digital therapeutics nrc live - sept 2018Chris Hogg
Thoughts on the past, present and future of digital therapeutics and digital medicines. Presentation for NRC Live Zorgtech Conference in Amsterdam, September 2018.
With @Atreja at the NODE Health Conference - Digital Medicine http://digitalmedicineconference.com/ on the events and studies which moved the field forward
PCHAlliance conducted a systematic review of published literature to gather the available data on health outcome measures, reviewing over 1,450 citations. Fifty-three randomized controlled studies and trials were selected for analysis, on topics related to mobile technologies, remote patient monitoring, web-based counseling and other personal connected health technologies. This publication aims to set an initial baseline for the current body of evidence in personal connected health in key areas, namely behavior change and self-care, remote patient monitoring, remote counseling and mental health, as well as more broadly through key condition-specific studies.
Download the paper here: http://www.pchalliance.org/personal-connected-health-state-evidence-and-call-action
Successfully Managing Chronic Health Conditions with Human-Centered Digital T...Cognizant
By adopting evidence-based digital therapeutics, healthcare organizations can alleviate the mounting costs of caring for patients with chronic conditions — and enter the fourth wave of digital healthcare.
Integrated Health Information to Examine, Empower and EngageH-Connect Compusoft
Electronic Ecosystem to build a universal Electronic Health Record and Health information exchange.
Deliver care through information technology,
Enhance health research, analysis & compliance
Improve efficiency, quality and reduce cost of healthcare. Online health records and Clinical Decision Support System (CDSS) at http://www.hconnect.co.in/
Digital is transforming healthcare. In this omnichannel age, patients expect better experience while expectations are often not met. This gap calls for an evolution in patient journey and experience research.
What are Digital Therapeutics? What are Digital Therapeutics not? What qualifies software as therapy? How do we research and develop Digital Therapeutics ? Why can DTx be disruptive? Threats and Opportunities for Pharma
Optimizing your EHR Value through Patient EngagementBrian Ahier
Focusing on the transformed healthcare system enabled by ARRA, hear ideas on how patients can help realize the value of your EHR and help you achieve meaningful use.
Judy Murphy, RN, FACMI, FHIMSS, FAAN
Deputy National Coordinator for Programs and Policy, Office of the National Coordinator for HIT
For more information contact: Slideshare@marcusevans.com
Presentation delivered by Joseph H. Schneider, MD, MBA, FAAP, Vice President and Chief Medical Information Officer and Medical Director, Clinical Informatics, North Texas, Baylor Scott and White Health at the marcus evans National Healthcare CMO/CMIO Summit 2015 at the Ritz-Carlton Buckhead Atlanta.
Clinician Satisfaction Before and After Transition from a Basic to a Comprehe...Allison McCoy
Healthcare organizations are transitioning from basic to comprehensive electronic health records (EHRs) to meet Meaningful Use requirements and improve patient safety. Yet, full adoption of EHRs is lagging and may be linked to clinician dissatisfaction. In depth assessment of satisfaction before, during, and after EHR transition is rarely done. Using an adapted published tool to assess adoption and satisfaction with EHRs, we surveyed clinicians at a large, non-profit academic medical center before (baseline) and 6-12 months (short-term follow-up) and 12-24 months (long-term follow-up) after transition from a basic, locally-developed to a comprehensive, commercial EHR. Satisfaction with the EHR (overall and by component) was captured at each interval. Overall satisfaction was highest at baseline (85%), lowest at short-term follow-up (66%), and increasing at long-term follow-up (79%). This trend was similar for satisfaction with EHR components designed to improve patient safety including clinical decision support, patient communication, health information exchange, and system reliability. Conversely, at baseline, short-term and long-term follow-up, perceptions of productivity, ability to provide better care with the EHR, and satisfaction with available resources, were lower at both short- and long-term follow-up compared to baseline. Persistent dissatisfaction with productivity and resources was identified. Addressing determinants of dissatisfaction may increase full adoption of EHRs. Further investigation in larger populations is warranted.
The presentation is about Electronic Health Records. The topic discusses the EHR implementation in organizations and their ongoing maintenance. The following topics are discussed: EHR functionalities, Benefits of EHR, EHR Implementation, After EHR Implementation, Policy in EHR
Evaluation of patient and clinician experience in the Lothian Telehealth trial. Alex Tarling
Evaluation of patient and clinician experience in the Lothian Telehealth trial. Presentation delivered at the World Congress for IT conference, Amsterdam, June 2010.
iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Current Evidence" Abha Agrawal, MD, FACP, COO & VP of Medical Affairs, Norwegian American Hospital
Case Study "The EHR & Quality: The Current Evidence"
∙ Understand where EHRs have demonstrated evidence based quality improvement
∙ Learn what areas for improvement exist to improve quality and physician productivity
∙ Discuss how results can be driven across diverse care settings and systems
∙ Identify unintended consequences of HIT
All You Ever Needed to Know About the Healthcare Design IndustrySara Marberry
So you want to work in healthcare design. What do you need to know about the industry? Here's a quick overview of some of the important stats, trends, resources, etc.
Health Information Exchange ( usage and benefits )Htun Teza
Presentation for RADS 601 ( Health Informatics and Health Information Technology ) - 20/11/19
Student of Master of Science in Data Science for Healthcare ( International Program ) ( Clinical Epidemiology and Biostatistics, Mahidol University, Thailand )
Patient View - The need for user-defined guidelines for health appsIn The Pocket
Dee O' Sullivan is an advocate for user-defined guidelines for health apps. In this presentation, she tells us why these guidelines are an absolute need in the healthcare industry.
Challenges of Summative Usability Testing in a Community Hospital Environment...David Schlossman MD
Findings of a summative scenario based ehr usability testing protocol and challenges of conducting the research in a private practice community hospital environment.
Workflow & Business Process Automation Opportunities in the Healthcare MarketY Soft Corporation
Wouter Koelewijn, Y Soft Vice President and Managing Director of Y Soft Scanning Division, talked about opportunities in workflow and business process automation for healthcare market in USA.
YSoft SafeQ is a leading print management and document capture solution currently uses by more than 14 000 companies in more than 100 countries.
If you want to find out more about YSoft SafeQ, contact us at www.ysoft.com/contact-us or schedule your Live Demo at www.ysoft.com/demo.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
1. M EANINGFUL U SE FOR
NYU C HAMPIONS
Leanthony Mathews, MSN, RN, CNML
LEANTHONY.MATHEWS@NYUMC.ORG
Presentation online at: http://bit.ly/NYUMUSLIDES
2. A GENDA
• Welcome
o Review of agenda and goals for the session
• History of Meaningful Use
• Define Meaningful Use
• Demo Epic Workflow MU Allergy objective
• Demo Epic Workflow MU Smoking objective
• Review Key Points
• Answer questions
• Next Steps
o Review homework
3. S ITUATION : P OOR
ADOPTION OF H.I.T.
• US lags behind other in industry
sectors and developed countries.
4. B ACKGROUND :
R EASONS
Cost
Software Quality and
Usability
Standards
5. A SSESSMENT: P OOR
H.I.T.:
• Medical Errors
• Increased
healthcare cost
• Decreased quality
of care
• Increase
paperwork
6. • Increase the adoption of
the Electronic Medical
Record (EMR)
• Advance Health
Information
Technology(HIT)
7. S OLUTION : HITECH
A CT
• Signed into Law Feb 17,2009 by
President Obama with a Goal by
2015 to:
o reduce the -cost of care
o Improve patient-health
centered care
o Enhance patient safety
o Improve population care
8. W HAT IS M EANINGFUL
U SE?
• Meaningful Use (MU) =
Objective measures
that hospital report as a
result of HITECH act.
9. M EANINGFUL U SE -
R EPORT C ARD
Hospital Reports on 21 Different
Objectives
11. M EANINGFUL U SE:
T HE RELIGION
• GIGO
• Adoption of
technology
Homework: What
one paper
• “Information
document in your
department do
wants to be free”
you feel Epic will
have problems
making
electronic?
12. W HY CHANGE ?
• Voluntary program and you attest to being a
MU.
• I don’t need an EHR to be a good clinician?
• Where do I find time to learn a new system?
• How do I find time to see patients and enter
my own data?
• It will slow me down?
• It so uncaring and not patient friendly.
• I like paper records!
13. I NCENTIVE : I MPROVE
PATIENT C ARE
o MU supports evidence based objectives to
improve patient outcome.
o MU supports patient-centric care that
engages patients and families
o MU helps reduce health disparities and
improve Population and Public Health
o MU improves care coordination
o DSS supports safe patient care
14. I NCENTIVE : R EVENUE
• $31 Billion Dollars available
for meaningful users of
electronic health systems.
• Hospital can receive
substantial income for
“meaningful use”
15. I NCENTIVE : N ON U SE
P ENALTY
• Penalties start in
2015
16. N EXT UP : E XAMPLES
• Any Questions
before we
move to
examples?
17. 21 C OMPONENTS OF
“M EANINGFUL U SE ”
• 1. Interoperability objectives
• 2. Objectives that measure clinical
use of EHR
18. MU O BJECTIVES : MEASURE
INTEROPERABILITY
Homework:
Currently,
what clinical
information
about your
patient do • Report hospital quality measures to CMS (Stoke, ED
you throughput)
constantly
struggle • Exchange clinical information with other institutions
locating in the
patient chart? • Submit electronic data to immunization registries
19. MU O BJECTIVES : MEASURE
CLINICAL USE OF EHR
• Computerized Practitioner Order Entry
(CPOE)
• Record demographics
• Maintain active medication list
Every Patient
Encounter • Maintain active problem list
Homework: • *Maintain active Allergy list
Currently,
which one • *Record smoking status for patients 13
Clinical MU
Measure does
years or older
your unit
struggle to
• Medication Reconciliation
complete?
20. MU R ULE : A LLERGY L IST
• Objective :Maintain active
medication allergy list.
• Measure : More than 80 percent of all
unique patients admitted to the eligible
hospital’s have at least one entry (or an
indication that the patient has no known
medication allergies) recorded as structured
data.
Evidence:
Adverse drug events in hospitalized patients. Excess
length of stay, extra costs, and attributable mortality.
JAMA. 1997 Jan 22-29;277(4):301-6.
21. W ORKFLOW TO MEET MU OR
ITEM
-Patient admitted using
Admission Navigator in
Epic.
-During your admission
suggested workflow you
Homework:
Describe one
will come to the allergies
clinical section.
workflow you
are concerned
that Epic EHR
will struggle to
capture,
specific to your
department?
22. W ORKFLOW TO MEET MU OR
ITEM
-Select No known allergies check box
-Select Mark as Reviewed.
-If patient leaves the hospital with no
data in the No known allergies measure
Fails.
24. E XAMPLE F INAL H OSPITAL
R EPORT
Allergy
Objective
(80%):
Out of 1287
patients seen:
92% (passed)
8% (failed)
25. MU R ULE : S MOKING S TATUS
• Objective :Record smoking
status for patients 13 years old
or older.
• Measure : More than 50 percent of all
unique patients 13 years old or older or
admitted to the eligible hospital’s inpatient
or emergency department have smoking
status recorded as structured data.
Evidence:
Smoking cessation counseling should be provided. Smokers
are 2 to 3 times more likely to get pneumonia than
nonsmokers and are at risk of more severe disease Cleve
Clin J Med. 2005 Oct;72(10):916-20.
26. W ORKFLOW TO MEET MU OR
ITEM
-Select Tobacco use status of patient.
-If patient leaves the hospital Never Assessed measure
Fails. All other sections give credit. Including Unknown
If Ever Smoked.
28. E ND OF YEAR R ESULTS FOR
S MOKING O BJECTIVE
Record Smoking
-End of the reporting
period
-For the entire Hospital
-Inpatient and ER
admissions
29. K EY TAKEAWAYS
• Key: Start with education of users on correct
workflow – Minimize Work Around
• Key: Real Time Documentation - Minimize
Batch Documentation
• Key: Utilize reports / Best Practice Advisories –
Reports and Advisories are your friend.
• Key: Standard data capture. Put information in
correct electric place - Paper is going away.
30. S OURCE READING
• Centers for Medicare & Medicaid Services
https://www.cms.gov
• The Meaningful Use Attestation Calculator
https://www.cms.gov/apps/ehr/
32. H OMEWORK
• Currently, what clinical information about your
patient to do you constantly struggle locating in
the patient chart?
• What one paper document in your department
do you feel Epic will have problems making
electronic?
• Currently, which one Clinical MU Measure does
your unit struggle to complete?
• Describe one clinical workflow you are
concerned that Epic EHR will struggle to capture,
specific to your department?
33. Thank you for your
Time!
This entire presentation can be found online at:
http://bit.ly/NYUMU2012
Please take 5 minutes to complete the Survey about MU in you area:
It can be found at: http://bit.ly/NYUMUSURVEY
Editor's Notes
Health Information Technology(HIT): framework management of health information across computerized systemsIncludes: -Electronic Medical Record (EMR)-Computerized Provider Order Entry(CPOE)-Secure health information Exchange and its secure exchange between consumers, providers, government and quality entities, and insurers.Patient
-Paper is cheap
Poor transfer of information outside of hospital
Improve health care quality;Prevent medical errors;Reduce health care costs;Increase administrative efficienciesDecrease paperwork; andExpand access to affordable care.
MU attestation is a report showing that an EH or EP is using a certified EHR technology to meet all the MU objectives.The system must compute and produce the report and can be audited at any time.
‘meaningful use,’ of HIT we recognize that better healthcare does not come solely from the adoption of technology itself, but through the exchange and use health information to best inform clinical decisions at the point of care.Not on paper on a clipboard or in someone pocket or head.
Noble / Tradition / First do no harm
1. Objectives that measure clinical use of EHR : Measure use of Use of certified EHR in a meaningful manner (e.g., e-prescribing, CPOE).2. Interoperability objectives: Use of EHR technology for electronic exchange of health information to improve quality of health care and public health.(Immunization, EMR to other institution)3. Objectives that show improved Quality Care of patients: Use of EHR technology to submit clinical quality measures (CQM) (Stroke, ED throughput).
To send the data, it must be structured. Write information in the write place.Information in notes or on paper can not be transmitted or used for DSS.
Smokers who quit after myocardial infarction lower their risk of death (compared with ongoing smokers) by up to 40%. Combined results from 12 studies with 2 to 10 years of follow up indicate that one life is saved for every 13 patients who can stop smoking (29).
-Abstracted and integrated the MU elements into the workflow.-Workflows-Utilize NYU approved best practice Epic workflows. -Always document “as it happens”-Work with your leadership to idenitfy key paper documents and confirm that they are on the crosswalk process for inclusion in Epic